home / stock / sbm:cc / sbm:cc news

SBM:CC News and Press, Sirona Biochem Corp. From 05/11/23

Stock Information
Company Name: Sirona Biochem Corp.
Stock Symbol: SBM:CC
Market: TSXVC
Website: sironabiochem.com
Menu
SBM:CC SBM:CC Quote SBM:CC Short SBM:CC News SBM:CC Articles SBM:CC Message Board
Get SBM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
SBM:CC - Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy

VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the Investing News Network has published an exclusive video interview with Dr. Geraldine Deliencourt-Godefroy, the Ch...
SBM:CC - Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) (" Sirona ") is excited to announce that Dr. Geraldine Deliencourt-Godefroy, Chief Scientific Officer, will be presenting the Company's latest anti-aging technology, TFC-1...

SBM:CC - Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326

VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona” ) is pleased to announce that the clinical trial results, for novel anti-aging compound TFC-1326, have exceeded even high expectations on key...

SBM:CC - Sirona Biochem Announces Close of Oversubscribed Debenture Financing

VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) (the “ Company ”) announced today that it has closed an oversubscribed, non-brokered convertible debenture for gross proceeds of $1,563,600. The p...
SBM:CC - Sirona Biochem Announces Debenture Financing

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) is pleased to announce a non-brokered private placement offering of unsecured, convertible debentures ...

SBM:CC - Sirona Biochem Receives Antiviral Testing Results

VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) is pleased to announce it has received results from its research collaboration with the International Centre for Genetic Engineering and...

SBM:CC - Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields

VANCOUVER, British Columbia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) announces the termination of the Rodan + Fields (R+F) agreement for supply and use of TFC-1067 in commercial formulations. Allergan Aest...
SBM:CC - Sirona Biochem Announces 2022 Annual Meeting Results

VANCOUVER, British Columbia, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on Decembe...

SBM:CC - Sirona Biochem Announces Start of Clinical Trial for Anti-Aging Compound TFC-1326

VANCOUVER, British Columbia, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) is pleased to announce that the clinical trial, for novel anti-aging compound TFC-1326, started on December 5 th , 2022. The trial...

SBM:CC - Sirona Biochem Signs International Partnership Agreement with Wanbang Biopharmaceuticals

VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) announces that, subsequent to the LOI , Sirona and Wanbang Biopharmaceuticals (“ Wanbang ”) have signed an expan...
Previous 10 Next 10